Vervloet Letícia Alves, Marguet Christophe, Camargos Paulo Augusto Moreira
Department of Pediatrics, Faculty of Medicine, Federal University of Minas Gerais, 190/Sala 4061, Santa Efigênia, Belo Horizonte, MG, Brazil.
Braz J Infect Dis. 2007 Oct;11(5):507-14. doi: 10.1590/s1413-86702007000500012.
This manuscript reviewed the literature on infection by Mycoplasma pneumoniae with emphasis on etiological aspects of childhood community-acquired pneumonias. Bibliographical research was carried out from Pubmed Medline, MDConsult, HighWire, LILACS, and direct research over the past 10 years with the following keywords: Mycoplasma pneumoniae, pneumonia, and childhood. Fifty-four articles were selected. Mycoplasma pneumoniae has a high incidence in childhood. Clinical presentation includes respiratory and extra-respiratory symptoms. Mycoplasma pneumoniae lung infection can be confused with viral or bacterial pneumonia and is unresponsive to beta-lactams. In addition, co-infections have been reported. Mycoplasma pneumoniae infection occurs in all age groups, being less frequent and more severe in children under the age of five. Its incidence as a causal agent is high. Mycoplasma pneumoniae infections constitute 20%-40% of all community-acquired pneumonias; the severity is highly variable, and this condition may lead to severe sequelae. Mycoplasma pneumoniae frequency is underestimated in clinical practice because of the lack of specific features and a diagnosis that needs serology or PCR. Effective management of M. pneumoniae infections can usually be achieved with macrolides. In Brazil, epidemiological studies are needed in order to assess the incidence of this bacterium.
本手稿回顾了关于肺炎支原体感染的文献,重点关注儿童社区获得性肺炎的病因学方面。通过Pubmed Medline、MDConsult、HighWire、LILACS进行文献研究,并在过去10年中使用以下关键词进行直接检索:肺炎支原体、肺炎和儿童。共筛选出54篇文章。肺炎支原体在儿童中发病率较高。临床表现包括呼吸道和呼吸道外症状。肺炎支原体肺部感染可能与病毒或细菌性肺炎混淆,且对β-内酰胺类药物无反应。此外,还报告了合并感染情况。肺炎支原体感染发生在所有年龄组,在5岁以下儿童中较少见但病情更严重。其作为病原体的发病率较高。肺炎支原体感染占所有社区获得性肺炎的20%-40%;严重程度差异很大,这种情况可能导致严重的后遗症。由于缺乏特异性特征以及需要血清学或PCR检测进行诊断,肺炎支原体感染在临床实践中的发生率被低估。肺炎支原体感染通常使用大环内酯类药物即可有效治疗。在巴西,需要进行流行病学研究以评估这种细菌的发病率。